Working group on pharma deals may help harmonize reviews while bringing ‘aggressive’ approach
A new transatlantic working group for mergers in the pharmaceutical sector will provide a chance to build on cooperation among regulators to help harmonize analysis, which has sometimes diverged in global...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: